Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Rumor Round Up<p>Rumor Activity was active to start out the week.</p><ul><li>Calcalist reported that Syneron Medical (<strong>ELOS 9.60 +0.30</strong>) is in talks to be acquired by Apax Partners.</li><li>M&A blogger Ben Harrington (Betaville) in weekly video interview discusses unsubstantiated speculation of PE interest in ZELTIQ Aesthetics (<strong>ZLTQ 55.70 +6.29</strong>); also discussed vague chatter that Allergan (<strong>AGN 247.87 +1.51</strong>) may be interested in Cynosure (<strong>CYNO 50.83 -4.23</strong>).</li><li>CNBC's David Faber reported a potential takeover of Macy's (<strong>M 33.14 +1.15</strong>) by Hudson's Bay (<strong>HBAYF 8.91 +0.32</strong>) seems unlikely.</li><li>Gilead Sciences (<strong>GILD 67.52 +1.16</strong>) activist chatter circulated,</li><li>Sunday Times UK reported on possible buyers for The Body Shop from Loreal (<strong>LRLCY 36.81 +0.55</strong>).</li><li>Telegraph reported that hedge funds support Fox (<strong>FOXA 29.86 -0.05</strong>) planned M&A deal with Sky (<strong>SKYAY 50.19 +0.23</strong>).</li></ul><p>While many rumors circulate during the day, and the validity of the source of these rumors can be questionable, the speculation may increase volatility in the near term</p></td> </tr></table>"